Supplementary Table 2 from A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor–Positive Breast Cancer: The BRACELET-01/PrE0113 Study
| Title: | Supplementary Table 2 from A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor–Positive Breast Cancer: The BRACELET-01/PrE0113 Study |
|---|---|
| Authors: | Amy S. Clark; Fengmin Zhao; Paula Klein; Alberto J. Montero; Carla Falkson; Elisa Krill-Jackson; Kendrith Rowland; Sagar Sardesai; Jason Incorvati; Patrick Dillon; Antonio C. Wolff; Richard Trauger; Thomas C. Heineman; Matthew C. Coffey; Kathy D. Miller |
| Publication Year: | 2025 |
| Collection: | Torrens University Australia: Figshare |
| Subject Terms: | Cancer; Immuno-oncology; Clinical Research and Trials; Breast Cancer; Clinical Trial Results; Phase II clinical trials; Immunotherapy |
| Description: | Supplementary Table 2. Representativeness of Study Participants. |
| Document Type: | article in journal/newspaper |
| Language: | unknown |
| Relation: | https://figshare.com/articles/journal_contribution/Supplementary_Table_2_from_A_Phase_II_Randomized_Study_of_Paclitaxel_Alone_or_Combined_with_Pelareorep_with_or_without_Avelumab_in_Metastatic_Hormone_Receptor_Positive_Breast_Cancer_The_BRACELET-01_PrE0113_Study/29444908 |
| DOI: | 10.1158/1078-0432.29444908 |
| Availability: | https://doi.org/10.1158/1078-0432.29444908 |
| Rights: | CC BY |
| Accession Number: | edsbas.49CFA10 |
| Database: | BASE |